Wells Fargo Upgrades Neurocrine Bio. (NBIX) to Overweight 'as the Company is Knocking on the Doors of the Large-Cap Club'
Tweet Send to a Friend
(Updated - April 24, 2024 5:42 AM EDT)
Wells Fargo analyst Mohit Bansal upgraded Neurocrine Bio. (NASDAQ: NBIX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wells Fargo analyst Mohit Bansal upgraded Neurocrine Bio. (NASDAQ: NBIX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
